利替培南酯
- 中文名称：
- 利替培南酯
- 中文别名：
-
- 英文名称：
- 4-Thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylicacid, 3-[[(aminocarbonyl)oxy]methyl]-6-[(1R)-1-hydroxyethyl]-7-oxo-,(acetyloxy)methyl ester, (5R,6S)-
- 英文别名：
- Acetoxymethyl (5R,6S)-3-[(carbamoyloxy)methyl]-6-[(1R)-1-hydroxye thyl]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate;
Ritanserinum [Latin];
Ritanserine;
Ritanserinum;
Ritanserine [French];
ritanserin;
Ritanserina;
risperidone;
Acetoxymethyl(5R,6S)-2-carbamoyloxy-methyl-6-[1(R)hydroxyethyl]penem-3-carboxylate;
Tiserton;
Ritanserina [Spanish]
- CAS No.：
- 87238-52-6
- 分 子 式：
-
C13H16N2O8S
- 分 子 量：
- 0
- 精确分子量：
- 360.06300
- PSA：
- 171.75000
- InChI：
- The Key: FZKGLCPKPZBGLX-ROXVQFJHSA-N3
- 分子结构式：
-
- SDS：
- 查看
利替培南酯 物化性质
- 密度：
- 1.57g/cm3
- 沸点：
- 656ºC at 760 mmHg
- 闪点：
- 350.6ºC
- 折射率：
- 1.62
利替培南酯 毒理性
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- XI0192000
- CHEMICAL NAME :
- 4-Thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic
acid, 3-(((aminocarbonyl)oxy)methyl)-6-
(1-hydroxyethyl)-7-oxo-, (acetyloxy)methyl ester,
(5R-(5-alpha,6-alpha(R*)))-
- CAS REGISTRY NUMBER :
- 87238-52-6
- LAST UPDATED :
- 199612
- DATA ITEMS CITED :
- 5
- MOLECULAR FORMULA :
- C13-H16-N2-O8-S
- MOLECULAR WEIGHT :
- 360.37
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- >5 gm/kg
- TOXIC EFFECTS :
- Behavioral - somnolence (general depressed activity)
Behavioral - convulsions or effect on seizure threshold
Lungs, Thorax, or Respiration - dyspnea
- REFERENCE :
- JACHDX Journal of Antimicrobial Chemotherapy. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1975- Volume(issue)/page/year:
23(Suppl C),129,1989
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 4363 mg/kg
- TOXIC EFFECTS :
- Behavioral - somnolence (general depressed activity)
Behavioral - convulsions or effect on seizure threshold
Lungs, Thorax, or Respiration - dyspnea
- REFERENCE :
- JACHDX Journal of Antimicrobial Chemotherapy. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1975- Volume(issue)/page/year:
23(Suppl C),129,1989
** OTHER MULTIPLE DOSE TOXICITY DATA **
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 91 gm/kg/26W-I
- TOXIC EFFECTS :
- Kidney, Ureter, Bladder - urine volume decreased
Kidney, Ureter, Bladder - other changes in urine composition
Biochemical - Metabolism (Intermediary) - lipids including transport
- REFERENCE :
- TOPADD Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert
Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)-
1978- Volume(issue)/page/year: 23,34,1995
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 42 gm/kg/2W-I
- TOXIC EFFECTS :
- Related to Chronic Data - death
- REFERENCE :
- JACHDX Journal of Antimicrobial Chemotherapy. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1975- Volume(issue)/page/year:
23(Suppl C),129,1989
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Primate - monkey
- DOSE/DURATION :
- 73 gm/kg/26W-I
- TOXIC EFFECTS :
- Kidney, Ureter, Bladder - other changes
Kidney, Ureter, Bladder - changes in bladder weight
- REFERENCE :
- TOPADD Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert
Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)-
1978- Volume(issue)/page/year: 23,34,1995
